Skip to content

Glossary

Ginsenosides

Ginsenosides are triterpene saponins, also called ginseng saponins, found almost exclusively in Panax species and concentrated in the roots. They are regarded as the major active constituents of Panax ginseng.

What it means in practice

Ginseng contains about thirty ginsenosides, which are triterpene glycosides, meaning a triterpene core with sugar groups attached [3]. Some, called rare ginsenosides (such as Rg3, Rh2 and compound K), occur naturally only in small amounts and are mostly produced when processing or gut metabolism removes sugar groups or changes the side chain [4].

Ginsenosides are heavily processed in the body. Most naturally occurring ginsenosides are deglycosylated by colon bacteria into intestinal metabolites [2], and only 0.2%–1.2% are excreted intact in urine [3]. This is why the ginsenosides listed on a label are not the only compounds of interest in absorption studies.

Not every product sold as "ginseng" contains them. Siberian ginseng contains eleutherosides, but not ginsenosides [3].

Why it matters when reading nootropics research

Ginseng extracts can be specified by ginsenoside content. Health Canada's Panax ginseng monograph, for example, lists extracts standardized to 4-7% total ginsenosides [5]. Two products with the same weight of ginseng can differ in ginsenoside content, so the extract and its standardization belong in any comparison between studies.

Product differences also make studies hard to compare. A review of ginseng interaction research found that preclinical results were largely inconclusive because studies used different ginseng products and methods [2]. When reading a ginseng trial, look for the species (Panax ginseng or another plant), the extract and its stated ginsenoside percentage.

For the graded evidence, see Panax ginseng.

References

  1. Kim YJ, Zhang D, Yang DC. Biosynthesis and biotechnological production of ginsenosides. Biotechnol Adv. 2015.PMID 25747290DOI 10.1016/j.biotechadv.2015.03.001Tier 1, narrative review
  2. Ramanathan MR, Penzak SR. Pharmacokinetic Drug Interactions with Panax ginseng. Eur J Drug Metab Pharmacokinet. 2017.PMID 27864798DOI 10.1007/s13318-016-0387-5Tier 1, narrative review
  3. Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem Toxicol. 2017.PMID 28698154DOI 10.1016/j.fct.2017.07.019Tier 1, narrative review
  4. Fan W, Fan L, Wang Z, et al. Rare ginsenosides: A unique perspective of ginseng research. J Adv Res. 2024.PMID 38195040DOI 10.1016/j.jare.2024.01.003Tier 1, narrative review
  5. Health Canada, Natural and Non-prescription Health Products Directorate. Panax ginseng (NHPID monograph). Updated June 27, 2025.SourceTier 1

Articles that mention this term

All glossary terms